Ridge Augmentation Using Allograft Particles Hydrated With or Without

Status Recruiting

Clinical Trial Summary

This study will compare two techniques to achieve increase in ridge dimensions as a preparation for dental implants using a resorbable barrier membrane and bone particulate allogenic graft hydrated with saline or a growth factor called Recombinant Human Platelet-Derived Growth Factor (rhPDGF).

Clinical Trial Description

This is a prospective, randomized, and examiner-only-masked study. It is designed to clinically compare the use of bone particulate allograft hydrated with rhPDGF vs bone particulate allograft hydrated with saline, for patients who were planned to receive dental implants but presented with deficient bone ridges. This investigation of two techniques to achieve increase in ridge dimensions as a preparation for dental implants using a resorbable barrier membrane and bone particulate allogenic graft hydrated with saline or a growth factor called Recombinant Human Platelet-Derived Growth Factor (rhPDGF). In two arms, bone core biopsies will be harvested at time of implant placement 4 months following ridge augmentation grafting. These 2x8mm bone cores will then undergo histological and histomorphometrical analyses to determine qualitative and quantitative healing differences between in both study arms. Clinical measurements are gathered at 2 time points (grating and implant placement) at all defects and will be compared for differences. Cone beam computed tomography (CBCT) initial scans are conducted immediately following prior to ridge augmentation and second scans obtained prior to implant placement both arms. These types of Cone Beam CT scans as well as conventional dental x-rays are valuable treatment planning tools that are commonly used in modern-day implant dentistry. The scans and the x-ray images are also used to monitor the health of tissues surrounding implants and to make sure that the implant remains securely implanted into the jawbone over time. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04954664
Study type	Interventional
Source	University of Alabama at Birmingham
Contact	Hussein Basma, DDS, MS
Phone	205-934-2888
Email	basma86@uab.edu
Status	Recruiting
Phase	N/A
Start date	August 11, 2021
Completion date	September 2025

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT04043286` - The Effects of Dis/Reconnection of Implant Abutments on Peri-implant Bone Levels	N/A
Recruiting	`NCT03046147` - The Effect of Roux-en-Y Gastric Bypass on Bone Turnover	N/A
Completed	`NCT01292395` - Effects of Dietary Protein on Musculoskeletal Health During Calorie Deficiency	N/A
Completed	`NCT00485953` - Effect of Bisphosphonate on Bone Loss in Postmenopausal Women With Breast Cancer Initiating Aromatase Inhibitor Therapy	Phase 4
Completed	`NCT00674453` - The Prevention Of Postmenopausal Osteoporosis With Lasofoxifene And Cytokine Evaluation	Phase 2
Completed	`NCT00181584` - Zoledronic Acid to Prevent Bone Loss During Androgen Deprivation Therapy for Prostate Cancer	Phase 2
Withdrawn	`NCT04380155` - Cycling Duration and Bone Markers in in Active Young Adults	N/A
Active, not recruiting	`NCT04779216` - Effects of Romosozumab on Bone Density in Women With Anorexia Nervosa	Phase 3
Completed	`NCT05371418` - Comparative Clinical and Radiographical Evaluation of Treatment of Angular Bone Defect Related to Over Erupted Tooth Using GTR Followed by Orthodontic Intrusion Versus Orthodontic Intrusion Followed by GTR	N/A
Not yet recruiting	`NCT04345250` - Bone Response to Exercise and Energy Restriction in Young Adults	N/A
Active, not recruiting	`NCT05405894` - Efficacy of Zoledronic Acid to Prevent Bone Loss Following Denosumab Discontinuation
Active, not recruiting	`NCT05301400` - Marginal Bone Loss in Single Implant Restaurations With Different Methods	N/A
Recruiting	`NCT04983758` - 20-year Implant Survival in Periodontally Healthy and Compromised Patients
Recruiting	`NCT04713774` - Bone Density and Vascular Calcifications Evolution After Renal Transplant
Completed	`NCT04279392` - Healthy Body, Healthy Bones After Bariatric Surgery Trial	Phase 1/Phase 2
Completed	`NCT04332679` - Non-resorbable Membranes Versus Titanium Meshes and Resorbable Membranes	N/A
Completed	`NCT05721014` - Effects of OsteoStrong vs. Individually Adapted and Combined Training on Bone Health	N/A
Recruiting	`NCT04883502` - Study of the Role of the Induced Membrane in the Reconstruction of Bone Loss in the Limbs
Not yet recruiting	`NCT05066815` - Evaluation of Crestal Bone Loss Around Short Dental Implants As Affected By Two Suprastructure Materials	N/A
Completed	`NCT03292146` - Effects of Denosumab on Bone Mineral Density in Women With Anorexia Nervosa: A Pilot Study	Phase 3

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Ridge Augmentation Using Allograft Particles Hydrated With or Without Recombinant Human Platelet-Derived Growth Factor

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms